BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 35973872)

  • 21. Human papillomavirus epidemiology in populations with normal or abnormal cervical cytology or cervical cancer in the Middle East and North Africa: A systematic review and meta-analysis.
    Obeid DA; Almatrrouk SA; Alfageeh MB; Al-Ahdal MNA; Alhamlan FS
    J Infect Public Health; 2020 Sep; 13(9):1304-1313. PubMed ID: 32564935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between human papillomavirus and bladder cancer: Evidence from meta-analysis and two-sample mendelian randomization.
    Sun JX; Xu JZ; Liu CQ; An Y; Xu MY; Zhong XY; Zeng N; Ma SY; He HD; Hu J; Liu Z; Wang SG; Xia QD
    J Med Virol; 2023 Jan; 95(1):e28208. PubMed ID: 36226344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus infection and colorectal cancer risk: a meta-analysis.
    Damin DC; Ziegelmann PK; Damin AP
    Colorectal Dis; 2013 Aug; 15(8):e420-8. PubMed ID: 23895733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-risk HPV prevalence among women undergoing cervical cancer screening: Findings a decade after HPV vaccine implementation in British Columbia, Canada.
    Litwin C; Smith L; Donken R; Krajden M; van Niekerk D; Naus M; Cook D; Albert A; Ogilvie G
    Vaccine; 2021 Aug; 39(36):5198-5204. PubMed ID: 34344555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
    Rajendra S; Sharma P
    Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.
    Jia M; Han J; Hang D; Jiang J; Wang M; Wei B; Dai J; Zhang K; Guo L; Qi J; Ma H; Shi J; Ren J; Hu Z; Dai M; Li N
    Tumour Biol; 2016 Jun; 37(6):8019-25. PubMed ID: 26711785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymerase Chain Reaction Human Papillomavirus (HPV) Detection and HPV Genotyping in Invasive Cervical Cancers With Prior Negative HC2 Test Results.
    Tao X; Zheng B; Yin F; Zeng Z; Li Z; Griffith CC; Luo B; Ding X; Zhou X; Zhao C
    Am J Clin Pathol; 2017 May; 147(5):477-483. PubMed ID: 28340235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is human papillomavirus and p16 expression associated with survival outcomes in nasopharyngeal cancer?: A systematic review and meta-analysis.
    Tham T; Teegala S; Bardash Y; Herman SW; Costantino P
    Am J Otolaryngol; 2018; 39(6):764-770. PubMed ID: 30029797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The negative conversion of high-risk human papillomavirus and its performance in surveillance of cervical cancer after treatment: a retrospective study.
    Song D; Kong WM; Zhang TQ; Jiao SM; Chen J; Han C; Liu TT
    Arch Gynecol Obstet; 2017 Jan; 295(1):197-203. PubMed ID: 27619686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Distribution of human papillomavirus (HPV) among HPV positive cervical adenocarcinoma cases detected by laser capture microdissection(LCM)].
    Liu B; Wu ZN; Liu XY; Sun HK; Li Q; Lin CQ; Zeng L; Cui JF; Yu XH; Zhang X; Li L; Chen W
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):277-82. PubMed ID: 27087374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neovaginal Human Papillomavirus Prevalence in Transfeminine Individuals: A Systematic Review.
    Nandwana D; Hawes K; Zuend CF; Pope R
    Obstet Gynecol; 2023 Aug; 142(2):296-306. PubMed ID: 37411025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
    Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL
    Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia.
    Panigoro R; Susanto H; Novel SS; Hartini S; Sahiratmadja E
    Asian Pac J Cancer Prev; 2013; 14(10):5843-7. PubMed ID: 24289587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival Rates for Patients With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma With or Without Human Papillomavirus Infection.
    Rajendra S; Xuan W; Merrett N; Sharma P; Sharma P; Pavey D; Yang T; Santos LD; Sharaiha O; Pande G; Cosman P; Wu X; Wang B
    JAMA Netw Open; 2018 Aug; 1(4):e181054. PubMed ID: 30646096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis.
    Bogale AL; Belay NB; Medhin G; Ali JH
    Virol J; 2020 Nov; 17(1):179. PubMed ID: 33198743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implication of human papillomavirus types and species in cervical cancer patients undergoing primary treatment.
    Lau YM; Cheung TH; Yeo W; Mo F; Yu MY; Lee KM; Ho WC; Yeung AC; Law PT; Chan PK
    PLoS One; 2015; 10(4):e0122557. PubMed ID: 25855986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Primary study on the relationship between high-risk HPV infection and vaginal cervical microbiota].
    Zhang Z; Zhang D; Xiao BB; Zhang R; Bai HH; Dong HY; Bi H; Liu ZH
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):471-480. PubMed ID: 30078257
    [No Abstract]   [Full Text] [Related]  

  • 38. Human papillomavirus infection and colorectal cancer in the Chinese population: a meta-analysis.
    Zhang XH; Wang W; Wang YQ; Jia DF; Zhu L
    Colorectal Dis; 2018 Nov; 20(11):961-969. PubMed ID: 30199598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.
    Thorsteinsson K; Ladelund S; Storgaard M; Katzenstein TL; Johansen IS; Pedersen G; Rönsholt FF; Nielsen LN; Nilas L; Franzmann M; Obel N; Lebech AM; Bonde J
    BMC Infect Dis; 2019 Aug; 19(1):740. PubMed ID: 31438877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
    Ramanakumar AV; Naud P; Roteli-Martins CM; de Carvalho NS; de Borba PC; Teixeira JC; Blatter M; Moscicki AB; Harper DM; Romanowski B; Tyring SK; Ramjattan B; Schuind A; Dubin G; Franco EL;
    BMJ Open; 2016 Aug; 6(8):e011371. PubMed ID: 27566633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.